A mining firm’s conflict with Argentinian communities illustrates extractive industry’s practices and values, and raises questions about how these corporate approaches will translate into the psychedelic pharmaceutical industry.

Canadian mining and exploration company AIS has had a number of executives move on to found psychedelic pharmaceutical businesses. Why? Because psychedelics are where the money’s at.

Recorded live (online) at the Capital Psychedelic Summit in Washington D.C., the Plus Three crew picks up the threads of a recent panel discussion about the effects of corporations and capitalism on the emerging psychedelic landscape. Examining the logic of capitalism, the realities of medicalization, and the need for radical social transformations, we explore philosophies underlying the "Grow, Gather, Give" model, which the Capital Psychedelic Summit organizers explicitly centered for this event.

The following is an open letter by two former co-leads of the MAPS Canada Diversity Committee. It was written in response to a variety of racist and prejudicial behaviours they experienced from MAPS Canada leadership and the organization at large during their eight-month tenure as unpaid volunteers, including obstruction—by leadership—of their efforts to address long-entrenched discriminatory practices in the psychedelic research domain and to implement initiatives to combat race-based health disparities.

When the media republishes statements from psychedelic pharmaceutical startups and their executives with little-to-no vetting, it functions as a corporate megaphone and damages the field of psychedelic science.

Terence McKenna once mused, “Conspiracy theory is a kind of epistemological cartoon about reality.” Looking around at the world, things appear awfully cartoonish at the moment. We're joined by Psymposia Senior Writer, Russell Hausfeld, to discuss the propagation of coronavirus conspiracies, recent revelations about QAnon, and the likelihood that some "conspiracy" claims are simply warped articulations of systemic critique. 5G won't give you COVID-19, but it sure will help you download this episode faster.

Through EmpathBio, ATAI Life Sciences says it will develop “safer” MDMA derivatives for patients with PTSD and calls the Multidisciplinary Association for Psychedelic Studies' (MAPS) approach "MDMA 1.0." MAPS' executive director, Rick Doblin, says that if that's the case, ATAI is "MDMA 0.5."

Since COMPASS Pathways filed for a controversial psilocybin patent in 2018, Usona Institute has consistently placed its research findings in the public domain.

Dr. Ido Hartoghson joins the show to talk about the ideas in his new book, American Trip: Set, Setting, and the Psychedelic Experience in the Twentieth Century  Acknowledging psychedelics as non-specific amplifiers of consciousness, we discuss different historical (and present) paradigms of use in order to interrogate the role of psychedelics within our culture. As we find ourselves staring down a number of existential questions, we must ask ourselves, "What do we hope to achieve through our personal and cultural exposure to psychedelics?”

Conspiracy theories are nothing new when it comes to psychedelia. But in the context of coronavirus, they've become significantly more harmful.

In response to the unexpected early release of William Leonard Pickard from prison, we discuss some of the characters and stories surrounding the case. Having served twenty years of a double life sentence for conspiracy to manufacture, distribute, and dispense LSD— charges which he disputes— Pickard has never spoken publicly about the specifics of his case, and some of the drug-media coverage of this story has evidenced glaring omissions. Using court documents, lesser-known first-person accounts, and excerpts from Pickard's book, The Rose of Paracelsus: On Secrets & Sacraments, we call attention to some of the murkier aspects of this story in an attempt to paint a fuller picture of what is, perhaps, the most notorious psychedelic story of the 21st century.

In this episode, we explore the implications of MAPS’ main political strategy: demonstrating affinity for and utility to the police, the military, the far right, and individuals who have repeatedly upheld violent white supremacism. Unpacking a recent article by David Nickles, we examine the “ends justifies the means” logic that has become pervasive in psychedelic research.

As Israel prepares to annex settlements in the West Bank and the Jordan Valley—with US support—what is the expected role of psychedelics in resolving the Palestine-Israel conflict?

In this episode, we unpack some of the characters and dynamics of the psychedelic “arm” of the Intellectual Dark Web. We use Neşe Devenot’s recently released video on Jamie Wheal, Lucian Tarnowski, and other affiliates of the Rebel Wisdom media platform to explore questions of power, class, and ahistorical theories of social change. Just how much sense do these self-labelled "sensemakers" make?

MAPS claims the most sustainable way to produce commercial MDMA is through the use of petrochemical feedstocks.

LSD chemist and longtime drug war prisoner, William Leonard Pickard, was officially released from prison on July 27, 2020. Pickard had been locked down since 2000 and was slated to serve two life sentences without the possibility of parole.

For decades, MAPS and other proponents of psychedelic medicalization have justified their emphasis on treating police and soldiers as a political strategy in service to mainstreaming psychedelic drugs. This strategy perpetuates the logic of white supremacism, capitalism, and imperialism.

Two of our biggest crises—COVID-19 and climate change—lay bare the magical thinking that pervades psychedelic discourse: that individual experiences of oneness will necessarily transform our society for the better.

The current spotlight on toxic law enforcement culture has propelled conversations about facial recognition and biometric surveillance into mainstream politics. Banning facial recognition is necessary to avoid automating racism and further institutionalizing white supremacy.

Brian, Dave, and Russell continue their conversation about neoliberals in psychedelia, including companies using the coronavirus pandemic to promote psychedelics for mental health. They also deconstruct non-profit vs. for-profit rhetoric and propose more pragmatic frameworks for examining the implications (and material realities) of psychedelic corporations and their operating structures, such as cooperative vs. non-cooperative.

Brian and Dave are joined by Psymposia writer Russell Hausfeld to discuss capitalist logic in psychedelia, the principles of open science, and the increasing eagerness of extractive industry players (including gold and lithium mining outfits and traders) looking to capitalize on psychedelics.

American policing is a white supremacist institution that has repeatedly demonstrated the degree to which it values property over human life. Our struggles against the police are inseparably entwined with similar struggles around the world, and they cannot be disconnected from larger struggles for human rights.

Aldous Huxley's thoughts on “progress” in capitalist democracies, why people take drugs, and the role of psychedelics in people's lives.

Sexual violence is already notoriously under-reported, and barriers— including distrust in police—are amplified when victims are also members of a criminalized subculture and were under the influence of illegal drugs when the violence occurred.

In this episode, Lily Kay Ross joins us to discuss Olivia Goldhill’s story, “Psychedelic therapy has a sexual abuse problem.” Ross recently completed her doctorate studying social responses to sexual violence. She brings both her personal experience with sexual violence and poor community responses in psychedelic spaces and her academic insights to bear on the myriad of questions highlighted by Goldhill’s reporting.